⌘K

Protara Therapeutics, Inc. (TARA)

$1.86 -2.37% $-0.04 Healthcare

Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the identifying and advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy for the treatment of lymphatic malformations. It also develops intravenous choline chloride, an investigational phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease. The company was formerly known as ArTara Therapeutics, Inc. and changed its name to Protara Therapeutics, Inc. in May 2020. Protara Therapeutics, Inc. is headquartered in New York, New York.

Market cap

$38.27M

CEO

Mr. Jesse Shefferman

Full time employees

31.00

Headquarters

New York, NY

IPO Date

Oct 22, 2014

Price-to-earnings (PE) Ratio

-0.61

Earnings-per-share (EPS)

$-3.03

Cash ratio (TTM)

4.98

Current ratio (TTM)

11.49

Net profit margin (TTM)

0.00%

PE ratio (TTM)

-189.21

Price-to-book ratio (TTM)

168.10

Price-to-sales ratio (TTM)

0.00

Quick ratio (TTM)

10.93

Return on assets (TTM)

-77.28%

Return on equity (TTM)

-76.17%

Similar stocks (9)

Scholar Rock Holding Corporation

SRRK

$8.03 -6.52% $-0.56

Downtrend

Trevi Therapeutics, Inc.

TRVI

$2.95 -4.84% $-0.15

Uptrend

Ikena Oncology, Inc.

IKNA

$1.69 1.81% $0.03

Uptrend

Xilio Therapeutics, Inc.

XLO

$0.81 5.16% $0.04

Downtrend

Surrozen, Inc.

SRZN

$9.23 -5.11% $-0.50

Downtrend

Lyra Therapeutics, Inc.

LYRA

$0.27 -4.35% $-0.01

Downtrend

Vaccinex, Inc.

VCNX

$5.63 7.85% $0.41

Downtrend

Monopar Therapeutics Inc.

MNPR

$2.39 -1.24% $-0.03

Downtrend

TRACON Pharmaceuticals, Inc.

TCON

$0.07 0.00% $0.00

Downtrend

ETF Exposure (6)

iShares Micro-Cap ETF

IWC

0.00908%

$117.00 -1.56% $-1.85

Neutral

Vanguard Extended Market Index Fund Institutional Shares

VIEIX

$129.08 -1.69% $-2.22

Neutral

Vanguard Total Stock Market Index Fund

VITSX

$129.67 -1.71% $-2.25

Neutral

Vanguard Total Stock Market Index Fund

VTI

$266.44 -1.66% $-4.50

Neutral

Vanguard Total Stock Market Index Fund

VTSAX

$129.65 -1.71% $-2.25

Neutral

Vanguard Extended Market Index Fund

VXF

$170.15 -1.70% $-2.94

Neutral

Downtrend

Similar stocks (9)

Scholar Rock Holding Corporation

SRRK

$8.03 -6.52% $-0.56

Downtrend

Trevi Therapeutics, Inc.

TRVI

$2.95 -4.84% $-0.15

Uptrend

Ikena Oncology, Inc.

IKNA

$1.69 1.81% $0.03

Uptrend

Xilio Therapeutics, Inc.

XLO

$0.81 5.16% $0.04

Downtrend

Surrozen, Inc.

SRZN

$9.23 -5.11% $-0.50

Downtrend

Lyra Therapeutics, Inc.

LYRA

$0.27 -4.35% $-0.01

Downtrend

Vaccinex, Inc.

VCNX

$5.63 7.85% $0.41

Downtrend

Monopar Therapeutics Inc.

MNPR

$2.39 -1.24% $-0.03

Downtrend

TRACON Pharmaceuticals, Inc.

TCON

$0.07 0.00% $0.00

Downtrend

ETF Exposure (6)

iShares Micro-Cap ETF

IWC

0.00908%

$117.00 -1.56% $-1.85

Neutral

Vanguard Extended Market Index Fund Institutional Shares

VIEIX

$129.08 -1.69% $-2.22

Neutral

Vanguard Total Stock Market Index Fund

VITSX

$129.67 -1.71% $-2.25

Neutral

Vanguard Total Stock Market Index Fund

VTI

$266.44 -1.66% $-4.50

Neutral

Vanguard Total Stock Market Index Fund

VTSAX

$129.65 -1.71% $-2.25

Neutral

Vanguard Extended Market Index Fund

VXF

$170.15 -1.70% $-2.94

Neutral